3.6.4 Interventions 3.6.4.1 Probiotics Gut dysbiosis has been increasingly recognized as a contributor to cardiovascular disease (CVD) pathogenesis through mechanisms involving systemic inflammation and metabolic disruption, with probiotics and prebiotics emerging as promising strategies to restore microbiota balance and improve cardiovascular markers such as LDL cholesterol and high-sensitivity C-reactive protein (hs-CRP
Trichotomization: Q1vsQ4) reveals that a high expression of four genes (TDO2, IDO1, IDO2, and Slc7a11) involved in kynurenine synthesis, from tryptophan, and transport is associated with a worse prognosis [256]
Without the sulfite contribution, you might not experience any noticeable symptoms at all
At wellness clinics, NAD+ and glutathione are often delivered through IV therapy or injections
There is evidence that PD pathogenesis is associated to oxidative stress caused by ROS generated by a mitochondrial dysfunction in the respiratory chain [171]
Heres how the three options compare: A 2025 study published in Pharmaceutics noted that standard oral Glutathione has bioavailability challenges due to digestive breakdown and absorption barriers, which is why delivery methods that bypass the digestive system are often preferred
